260 related articles for article (PubMed ID: 31303452)
1. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
Borkenhagen JF; Bergom C; Rapp CT; Klawikowski SJ; Rein LE; Gore EM
Clin Lung Cancer; 2019 Nov; 20(6):435-441. PubMed ID: 31303452
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
Yegya-Raman N; Wang K; Kim S; Reyhan M; Deek MP; Sayan M; Li D; Patel M; Malhotra J; Aisner J; Marks LB; Jabbour SK
J Thorac Oncol; 2018 Oct; 13(10):1508-1518. PubMed ID: 29883836
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
Wang K; Eblan MJ; Deal AM; Lipner M; Zagar TM; Wang Y; Mavroidis P; Lee CB; Jensen BC; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
J Clin Oncol; 2017 May; 35(13):1387-1394. PubMed ID: 28113017
[TBL] [Abstract][Full Text] [Related]
4. Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer.
Xue J; Han C; Jackson A; Hu C; Yao H; Wang W; Hayman J; Chen W; Jin J; Kalemkerian GP; Matuzsak M; Jolly S; Kong FS
Radiother Oncol; 2019 Apr; 133():213-219. PubMed ID: 30416046
[TBL] [Abstract][Full Text] [Related]
5. Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer.
Contreras JA; Lin AJ; Weiner A; Speirs C; Samson P; Mullen D; Campian J; Bradley J; Roach M; Robinson C
Radiother Oncol; 2018 Sep; 128(3):498-504. PubMed ID: 29859754
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Ning MS; Tang L; Gomez DR; Xu T; Luo Y; Huo J; Mouhayar E; Liao Z
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):70-79. PubMed ID: 28816165
[TBL] [Abstract][Full Text] [Related]
7. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.
Wang K; Pearlstein KA; Patchett ND; Deal AM; Mavroidis P; Jensen BC; Lipner MB; Zagar TM; Wang Y; Lee CB; Eblan MJ; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
Radiother Oncol; 2017 Nov; 125(2):293-300. PubMed ID: 29050957
[TBL] [Abstract][Full Text] [Related]
8. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
[TBL] [Abstract][Full Text] [Related]
9. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
12. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
13. Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: clinical, dosimetric, and associated-treatment risk factors.
Leprieur EG; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
J Cancer Res Ther; 2013; 9(3):447-51. PubMed ID: 24125981
[TBL] [Abstract][Full Text] [Related]
14. Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy.
Wong OY; Yau V; Kang J; Glick D; Lindsay P; Le LW; Sun A; Bezjak A; Cho BCJ; Hope A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e241-e246. PubMed ID: 28941961
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy.
Etiz D; Bayman E; Akcay M; Sahin B; Bal C
Asian Pac J Cancer Prev; 2013; 14(7):4223-8. PubMed ID: 23991980
[TBL] [Abstract][Full Text] [Related]
16. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors.
Oh D; Ahn YC; Park HC; Lim DH; Han Y
Jpn J Clin Oncol; 2009 Mar; 39(3):151-7. PubMed ID: 19193653
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.
Bradley J; Deasy JO; Bentzen S; El-Naqa I
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1106-13. PubMed ID: 15001251
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.
Dess RT; Sun Y; Matuszak MM; Sun G; Soni PD; Bazzi L; Murthy VL; Hearn JWD; Kong FM; Kalemkerian GP; Hayman JA; Ten Haken RK; Lawrence TS; Schipper MJ; Jolly S
J Clin Oncol; 2017 May; 35(13):1395-1402. PubMed ID: 28301264
[TBL] [Abstract][Full Text] [Related]
19. Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy.
Jin Z; Sun X; Zhou C; Yang H; Zhou S
Neoplasia; 2024 Feb; 48():100969. PubMed ID: 38199173
[TBL] [Abstract][Full Text] [Related]
20. Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer.
Cella L; Monti S; Xu T; Liuzzi R; Stanzione A; Durante M; Mohan R; Liao Z; Palma G
Radiother Oncol; 2021 Jul; 160():148-158. PubMed ID: 33979653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
